Use, Persistence, Efficacy, and Safety of Apixaban in Patients with Non-Valvular Atrial Fibrillation in Unselected Patients in Germany. Results of the Prospective Apixaban in Atrial Fibrillation (APAF) Registry
暂无分享,去创建一个
U. Zeymer | H. Kabitz | T. Süselbeck | R. Prondzinsky | F. Richard | Christiane Lober | J. Taggeselle | H. Schäfer | A. Wolf